Metformin hydrochloride delayed release tablets – a comparative dissolution profiles study
Guardado en:
| Autores: | , , , , , |
|---|---|
| Formáid: | artículo original |
| Fecha de Publicación: | 2019 |
| Cur Síos: | Multisource or generic drugs represent an important decrease in treatment cost for multiple diseases, which improves patient’s medicine access. However, the therapeutic equivalence between original drugs (innovator) and generic or multisource drugs need to be demonstrated. Bioequivalence represents drug efficacy and higher security for patients, and it is considered as a fundamental factor for product commercialization. This work main objective was to make a comparison between the dissolution profiles of the original and multisource metformin hydrochloride tablets commercialized in Costa Rica. We used a validated analytical method to quantify metformin in dissolution medium, a phosphates buffered solution of pH (6.8 ± 0.05). The obtained results demonstrated products interchangeability using the model-independent similarity factor (f2) and difference factor (f1) criteria. |
| País: | Kérwá |
| Institiúid: | Universidad de Costa Rica |
| Repositorio: | Kérwá |
| Teanga: | Inglés |
| OAI Identifier: | oai:kerwa.ucr.ac.cr:10669/103087 |
| Rochtain Ar Líne: | https://hdl.handle.net/10669/103087 https://doi.org/10.30574/gscbps.2019.8.2.0119 |
| Palabra clave: | metformin hydrochloride tablets dissolution profiles multisource drugs |